The Alzheimer’s Association, through its Part the Cloud global research grant program, has awarded Wake Forest University School of Medicine $795,000 over two years to study potential treatments for Alzheimer’s disease.
Part the Cloud is designed to accelerate translation of findings from the laboratory, through trials, into possible therapies — filling the gap in Alzheimer’s drug development by providing essential support for clinical studies.
“Nearly 6 million Americans are living with…
